TY - JOUR
T1 - Oxidant stress with hydrogen peroxide attenuates calcium paradox injury
T2 - Role of protein kinase C and ATP-sensitive potassium channel
AU - Miyawaki, Hiroshi
AU - Wang, Yigang
AU - Ashraf, Muhammad
N1 - Funding Information:
This study was supported in part by NIH research grants HL23597 and HL55678 from the National Heart, Lung and Blood Institute. The authors thank Atif Ashraf for technical assistance.
PY - 1998/3
Y1 - 1998/3
N2 - Objective: We tested the hypOtheses that low concentration of H2O2 attenuates the Ca2+ paradox (Ca2+ PD) injury, and that activation of protein kinase C (PKC) and/or ATP-sensitive potassium channel (K(ATP)) are involved in the protective effects of H2O2. Methods: Langendorff-perfused rat hearts were subjected to the Ca2+ PD (10 rain of Ca2+ depletion followed by 10 min of Ca2+ repletion). Functional and biochemical effects of H2O2 and other interventions on the cell injury induced by the Ca2+ PD were assessed. Results: In the Ca2+ PD hearts pretreated with 20 μmol/l H2O2, left ventricular end-diastolic pressure and coronary flow were significantly preserved. Furthermore, peak lactate dehydrogenase release was significantly decreased and ATP contents were more preserved, compared with non-treated Ca2+ PD hearts. H2O2-treated hearts also showed remarkable preservation of cell structure. Addition of a specific PKC inhibitor, chelerythrine during H2O2 treatment completely abolished the beneficial effects of H202 on the Ca2+ PD. Similarly, an activator of PKC, Phorbol 12-myristate 13 acetate mimicked the protection by H2O2. Furthermore, pretreatment with a K(ATP) opener, cromakalim also provided protection similar to H2O2 against the Ca2+ PD injury. However, a specific K(ATP) inhibitor, glibenclamide was not able to completely block the effects of H2O2. Conclusions: These findings suggest that pretreatment with low concentration of H2O2 provides significant protection against the lethal injury of Ca2+ PD in rat hearts. PKC-mediated signaling pathways appear to play a crucial role in the protection against the Ca2+ PD injury.
AB - Objective: We tested the hypOtheses that low concentration of H2O2 attenuates the Ca2+ paradox (Ca2+ PD) injury, and that activation of protein kinase C (PKC) and/or ATP-sensitive potassium channel (K(ATP)) are involved in the protective effects of H2O2. Methods: Langendorff-perfused rat hearts were subjected to the Ca2+ PD (10 rain of Ca2+ depletion followed by 10 min of Ca2+ repletion). Functional and biochemical effects of H2O2 and other interventions on the cell injury induced by the Ca2+ PD were assessed. Results: In the Ca2+ PD hearts pretreated with 20 μmol/l H2O2, left ventricular end-diastolic pressure and coronary flow were significantly preserved. Furthermore, peak lactate dehydrogenase release was significantly decreased and ATP contents were more preserved, compared with non-treated Ca2+ PD hearts. H2O2-treated hearts also showed remarkable preservation of cell structure. Addition of a specific PKC inhibitor, chelerythrine during H2O2 treatment completely abolished the beneficial effects of H202 on the Ca2+ PD. Similarly, an activator of PKC, Phorbol 12-myristate 13 acetate mimicked the protection by H2O2. Furthermore, pretreatment with a K(ATP) opener, cromakalim also provided protection similar to H2O2 against the Ca2+ PD injury. However, a specific K(ATP) inhibitor, glibenclamide was not able to completely block the effects of H2O2. Conclusions: These findings suggest that pretreatment with low concentration of H2O2 provides significant protection against the lethal injury of Ca2+ PD in rat hearts. PKC-mediated signaling pathways appear to play a crucial role in the protection against the Ca2+ PD injury.
KW - Calcium
KW - K(ATP) channel
KW - Myocytes
KW - Preconditioning
KW - Protein kinase C
UR - http://www.scopus.com/inward/record.url?scp=0032029375&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032029375&partnerID=8YFLogxK
U2 - 10.1016/S0008-6363(97)00249-6
DO - 10.1016/S0008-6363(97)00249-6
M3 - Article
C2 - 9659453
AN - SCOPUS:0032029375
SN - 0008-6363
VL - 37
SP - 691
EP - 699
JO - Cardiovascular Research
JF - Cardiovascular Research
IS - 3
ER -